Disclaimer: this information is only to aid a healthy diet and not to reccomend using the ingredients in place of medication 
Check out some of 

THE BENEFITS OF TURMERIC (CURCUMIN) 

1. Anti-inflammatory  (Aging, Alzhimers, Arthiritus, Bowl disease, Cancer, Gastroprotective Action, Gut inflammation, Heart Disease, Metabolic Syndrome, Skin inflammation etc.) 
Inflammation has been identified in the development of many chronic diseases and conditions. These diseases include Alzheimer’s disease (AD), Parkinson’s disease, multiple sclerosis, epilepsy, cerebral injury, cardiovascular disease, metabolic syndrome, cancer, allergy, asthma, bronchitis, colitis, arthritis, renal ischemia, psoriasis, diabetes, obesity, depression, fatigue, and acquired immune deficiency syndrome AIDS... Curcumin has been shown to block NF-κB activation increased by several different inflammatory stimuli. Curcumin has also been shown to suppress inflammation through many different mechanisms beyond the scope of this review, thereby supporting its mechanism of action as a potential anti-inflammatory agent.  
- Hewlings, Susan J, and Douglas S Kalman. “Curcumin: A Review of Its Effects on Human Health.” Foods (Basel, Switzerland) vol. 6,10 92. 22 Oct. 2017, doi:10.3390/foods6100092  
"This agent has been shown to regulate numerous transcription factors, cytokines, protein kinases, adhesion molecules, redox status and enzymes that have been linked to inflammation. The process of inflammation has been shown to play a major role in most chronic illnesses, including neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. In the current review, we provide evidence for the potential role of curcumin in the prevention and treatment of various proinflammatory chronic diseases." 
- Bharat B. Aggarwal, Kuzhuvelil B. Harikumar, Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases, The International Journal of Biochemistry & Cell Biology, Volume 41, Issue 1, 2009, Pages 40-59, ISSN 1357-2725,

"In a similar randomized placebo-controlled single-blind pilot trial, 20 male healthy, moderately active volunteers were randomized to receive either 1 g curcumin twice daily (200 mg curcumin twice a day ) or a placebo 48 h prior to and 24 h after a downhill running test. Subjects in the curcumin group reported significantly less pain in the right and left anterior thigh. Significantly fewer subjects in the curcumin group had MRI evidence of muscle injury in the posterior or medial compartment of both thighs. Increases in markers of muscle damage and inflammation tended to be lower in the curcumin group, but significant differences were only observed for interleukin-8 at 2 h after exercise. No differences in markers of oxidative stress and muscle histology were observed. These results further support that curcumin may be beneficial to attenuate exercise-induced muscle soreness"
- Hewlings, Susan J, and Douglas S Kalman. “Curcumin: A Review of Its Effects on Human Health.” Foods (Basel, Switzerland) vol. 6,10 92. 22 Oct. 2017, doi:10.3390/foods6100092
2. Antioxidant 
"Curcuminoids which are described as natural antioxidants" 
- Turmeric, potion or poison?, Nataly Martini, vol 11, 2019, Journal of Primary Health Care. 

"Curcuminoids are proved to have strong antioxidant action demonstrated by the inibition of the formation and propagation of free radicals. It decreases the low-density lipoprotien oxidation and the free radicals that cause the deterioration of neurons, not only in AD but also in other neuron degenerative disorders such as Huntington's and Parkingson's disease" - Mishra, Shrikant, and Kalpana Palanivelu. “The effect of curcumin (turmeric) on Alzheimer's disease: An overview.” Annals of Indian Academy of Neurology vol. 11,1 (2008): 13-9. doi:10.4103/0972-2327.40220

"The animal modeling using high-fat diets can be utilized to assess the antioxidant activities of plants."
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 
3. Immunity 
"Curcumin may help the macrophages to clear the amyloid plaques found in Alzheimer's disease. Macrophages play an important role in the immune system. They help the body to fight against foreign proteins and then effectively clear them"
- Mishra, Shrikant, and Kalpana Palanivelu. “The effect of curcumin (turmeric) on Alzheimer's disease: An overview.” Annals of Indian Academy of Neurology vol. 11,1 (2008): 13-9. doi:10.4103/0972-2327.40220
4. Neurological 
Alzheimer's: 
The most prominent characteristic feature in AD (Alzheimer's disease) is the presence of beta-amyloid plaques. These plaques are basically an accumulation of small fibers called beta amyloid fibrils. Because the deposition of beta-amyloid protein is a consistent pathological hallmark of brains affected by AD, the inhibition of A-beta generation, prevention of A-beta fibril formation, destabilization of pre-formed A-beta would be an attractive therapeutic strategy for the treatment of AD...low doses of curcumin also caused a 43% decrease in the so-called “plaque burden” that these beta-amyloid have on the brains of AD mice. Surprisingly low doses of curcumin given over longer period were actually more effective than high doses in combating the neurodegenerative process of AD.
"curcumin has been shown to increase the phagocytosis of amyloid-beta, effectively clearing them from the brains of patients with AD"
"the overall memory in patients "with AD  has improved."
- Mishra, Shrikant, and Kalpana Palanivelu. “The effect of curcumin (turmeric) on Alzheimer's disease: An overview.” Annals of Indian Academy of Neurology vol. 11,1 (2008): 13-9. doi:10.4103/0972-2327.40220 

General: "Curcuminoids are proved to have strong antioxidant action demonstrated by the inibition of the formation and propagation of free radicals. It decreases the low-density lipoprotien oxidation and the free radicals that cause the deterioration of neurons, not only in AD but also in other neuron degenerative disorders such as Huntington's and Parkingson's disease" "Curcumin protects brain mitochondria against various oxidative stress [and] peroxynitrite" 
- Mishra, Shrikant, and Kalpana Palanivelu. “The effect of curcumin (turmeric) on Alzheimer's disease: An overview.” Annals of Indian Academy of Neurology vol. 11,1 (2008): 13-9. doi:10.4103/0972-2327.40220

Depression: 
"The antidepressant action of curcumin has been extensively studied in animal models and is found to be comparable to fluoxetine, imipramine, amitriptyline and bupropion (Yu et al., 2002; Xu et al., 2005; Xia et al., 2007; Kulkarni et al., 2008; Wang et al., 2008). Curcumin increases the brain levels of serotonin, noradrenaline and dopamine by inhibiting the Monoamine oxidases (MAO) enzyme (Yu et al., 2002; Xu et al., 2005; Xia et al., 2007; Kulkarni et al., 2008; Wang et al., 2008). Various metaanalyses have shown that MAO inhibitors like moclebemide have response rate of ~58% (Lotufo-Neto et al., 1999). Curcumin has also shown similar response rate like MAO inhibitors in this study, but as compared to others, it has proved to be safe even at supra-therapeutic doses. Furthermore, a combination of curcumin with other antidepressants has shown to synergistically increase the serotonin levels and enhance antidepressant like activity in various animal models (Kulkarni et al., 2008). Curcumin also increases hippocampal neurogenesis in chronically stressed rats via modulation of HPA axis and up regulation of 5-HT1A receptors and BDNF in the hippocampus (Xu et al., 2007). It inhibits the NF-kB activation pathways of innate immunity and thus prevents release of IFN-a and other cytokines. These cytokines lead to dysregulation of HPA axis, metabolism of monoamine neurotransmitters and neuronal plasticity. Thus, curcumin might be helpful in depression by interfering at an early stage in its pathogenesis (Lao et al., 2006; Raison and Miller, 2011). The advantage of curcumin as an antidepressant is its benign profile of adverse events as compared to other antidepressants." 
"This study provides first clinical evidence that curcumin may be used as an effective and safe modality for treatment in patients with MDD (Major depressive disorder) without concurrent suicidal ideation or other psychotic disorders." - Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, Goel A, Tripathi CB. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res. 2014 Apr;28(4):579-85. doi: 10.1002/ptr.5025. Epub 2013 Jul 6. PMID: 23832433. 

"The neurochemical assays showed that curcumin produced a marked increase of serotonin and noradrenaline levels at 10 mg/kg in both the frontal cortex and hippocampus". 
-  Ying Xu, Bao-Shan Ku, Hai-Yan Yao, Yan-Hua Lin, Xing Ma, Yong-He Zhang, Xue-Jun Li, The effects of curcumin on depressive-like behaviors in mice, European Journal of Pharmacology, Volume 518, Issue 1, 2005, Pages 40-46, ISSN 0014-2999 
5. Aging and Longevity 
Aging and longevity: If curcumin can really help prevent heart disease, cancer and Alzheimer’s, it would have obvious benefits for longevity... But given that oxidation and inflammation are believed to play a role in aging, curcumin may have effects that go way beyond just preventing disease."
- https://www.healthline.com/nutrition/top-10-evidence-based-health-benefits-of-turmeric#TOC_TITLE_HDR_11 

Skin: "some evidence exists for the use of curcumin in metabolic disorders due to its effects in lowering lipids, C-reactive protein and leptin, and in skin diseases due to its antioxidant, anti-infammatory activity, and possible antimicrobial activity."
- Turmeric, potion or poison? Nataly Martini, vol 11, 2019, Journal of Primary Health Care.  


6. Matters of the heart
"The antioxidant effects of curcumin have been shown to attenuate adriamycin-induced cardiotoxicity and may prevent diabetic cardiovascular complications. The anti-thrombotic, anti-proliferative, and anti-inflammatory effects of curcumin and the effect of curcumin in decreasing the serum cholesterol level may protect against the pathological changes occurring with atherosclerosis. The p300-HAT inhibitory effects of curcumin have been demonstrated to ameliorate the development of cardiac hypertrophy and heart failure in animal models. The inflammatory effects of curcumin may have the possibility of preventing atrial arrhythmias and the possible effect of curcumin for correcting the Ca2+ homeostasis may play a role in the prevention of some ventricular arrhythmias."
- Wongcharoen W, Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol. 2009 Apr 3;133(2):145-51. doi: 10.1016/j.ijcard.2009.01.073. Epub 2009 Feb 23. PMID: 19233493.

Background: Dyslipidemia is an important and common cardiovascular risk factor in the general population. The lipid-lowering effects of turmeric and curcumin are unconfirmed. We performed a meta-analysis to assess the efficacy and safety of turmeric and curcumin in lowering blood lipids in patients at risk of cardiovascular disease (CVD). 
 Methods: A comprehensive literature search was conducted on PubMed, Embase, Ovid, Medline and Cochrane Library databases to identify randomized controlled trials (published as of November 2016) that assessed the effect of turmeric and curcumin on blood lipid levels including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Pooled standardized mean difference (SMD) with 95% confidence interval (CI) was used to assess the effect. 
 Results: The analysis included 7 eligible studies (649 patients). Turmeric and curcumin significantly reduced serum LDL-C (SMD = -0.340, 95% confidence interval [CI]: -0.530 to -0.150, P < 0.0001) and TG (SMD = -0.214, 95% CI: -0.369 to -0.059, P = 0.007) levels as compared to those in the control group. These may be effective in lowering serum TC levels in patients with metabolic syndrome (MetS, SMD = -0.934, 95% CI: -1.289 to -0.579, P < 0.0001), and turmeric extract could possibly have a greater effect on reducing serum TC levels (SMD = -0.584, 95% CI: -0.980 to -0.188, P = 0.004); however, the efficacy is yet to be confirmed. Serum HDL-C levels were not obviously improved. Turmeric and curcumin appeared safe, and no serious adverse events were reported in any of the included studies. Conclusions: Turmeric and curcumin may protect patients at risk of CVD through improving serum lipid levels. Curcumin may be used as a well-tolerated dietary adjunct to conventional drugs. Further research is required to resolve uncertainties related to dosage form, dose and medication frequency of curcumin.
- Qin S, Huang L, Gong J, Shen S, Huang J, Ren H, Hu H. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J. 2017 Oct 11;16(1):68. doi: 10.1186/s12937-017-0293-y. PMID: 29020971; PMCID: PMC5637251.
7. Metabolic Syndrome 
"Curcumin has been shown to attenuate several aspects of Metabolic syndrome (MetS) by improving insulin sensitivity, suppressing adipogenesis, and reducing elevated blood pressure, inflammation, and oxidative stress. In addition, there is evidence that curcuminoids modulate the expression of genes and the activity of enzymes involved in lipoprotein metabolism that lead to a reduction in plasma triglycerides and cholesterol and elevate HDL-C concentrations. Both overweight and obesity are linked to chronic low-grade inflammation; although the exact mechanisms are not clear, it is known that pro-inflammatory cytokines are released. These cytokines are thought to be at the core of the complications associated with diabetes and cardiovascular disease. Therefore, addressing inflammation is important. In a randomized double-blind placebo-controlled trial with a parallel-group design, 117 subjects with MetS received either 1 g curcumin plus 10 mg piperine to increase absorption or a placebo plus 10 mg piperine for eight weeks. Within-group analysis revealed significant reductions in serum concentrations of TNF-α, IL-6, transforming growth factor beta (TGF-b), and monocyte chemoattractant protein-1 ( MCP-1) following curcumin supplementation (p < 0.001). In the placebo group, serum levels of TGF-b were decreased (p = 0.003) but those of IL-6 (p = 0.735), TNF-α (p = 0.138), and MCP-1 (p = 0.832) were not. Between-group comparison suggested significantly greater reductions in serum concentrations of TNF-α, IL-6, TGF-b, and MCP-1 in the curcumin versus the placebo group (p < 0.001). Apart from IL-6, changes in other parameters remained statistically significant after adjustment for potential confounders, including changes in serum lipids and glucose levels, as well as the baseline serum concentration of the cytokines. The results of this study suggest that curcumin supplementation significantly decreases serum concentrations of pro-inflammatory cytokines in subjects with MetS. In addition, the study looked at the cholesterol-lowering properties and found that curcuminoids were more effective than the placebo in reducing serum LDL-C, non-HDL-C, total cholesterol, triglycerides, and lipoprotein a (Lp(a)), in addition to elevating HDL-C concentrations." 
- Hewlings, Susan J, and Douglas S Kalman. “Curcumin: A Review of Its Effects on Human Health.” Foods (Basel, Switzerland) vol. 6,10 92. 22 Oct. 2017, doi:10.3390/foods6100092   
8. Arthritis 
"Several studies have shown the anti-arthritic effects of curcumin in humans with osteoarthritis (OA) and rheumatoid arthritis (RA). In a randomized double-blind placebo-controlled trial, 40 subjects with mild-to-moderate degree knee OA were randomly assigned to receive either curcuminoid (500 mg/day in three divided doses; n = 19) with 5 mg piperine added to each 500-mg dose or a matched placebo (n = 21) for six weeks. There were significantly greater reductions in the visual analog scale (VAS) (p < 0.001), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores (p = 0.001), and Lequesne’s pain functional index (LPFI) (p = 0.013) scores in the treatment group compared with the placebo group. When comparing the WOMAC subscales, there were significant improvements in the pain and physical function scores (p < 0.001), but not in the stiffness score. There was also a decrease in systemic oxidative stress, as measured via serum activities of SOD and concentrations of reduced GSH and malonedialdehyde (MDA), in subjects receiving the treatment as compared to the placebo...[The author suggests] that is more plausible that the beneficial effects of curcuminoids in OA are because of local anti-inflammatory effects rather than systemic effects." 

"In a longer (eight months) randomized control trial, 50 subjects diagnosed with OA were assigned to receive either standard treatment as prescribed by their physician or standard treatment plus two 500-mg tablets daily consisting of a natural curcuminoid mixture (20%), containing phosphatidyl-choline (40%) and microcrystalline cellulose (40%). WOMAC, physical function, and stiffness scores decreased significantly (p < 0.05) in the treatment group compared to the control. In addition, the treatment group showed significant decreases in all markers of inflammation (soluble CD40 ligand(sCD40L), interleukin 1 beta (IL-1β), interleukin 6 (IL-6), soluble vascular cell adhesion molecule 1 (sVCAM-1), and erythrocyte sedimentation rate (ESR) comparing baseline to follow-up, while the control group did not [37]. This study had both groups maintaining standard care, which does not address the question of whether or not supplementation with curcumin can be used instead of standard management such as nonsteroidal anti-inflammatory drugs (NSAIDS). To address this question, 367 primary knee osteoarthritis patients with a pain score of 5 or higher were randomized to receive ibuprofen 1200 mg/day or C. domestica extracts 1500 mg/day for four weeks. The mean of all WOMAC scores at weeks 0, 2, and 4 showed significant improvement when compared with the baseline in both groups. After using the noninferiority test, the mean difference (95% confidence interval) of WOMAC total, WOMAC pain, and WOMAC function scores at week 4 adjusted by values at week 0 of C. domestica extracts were non-inferior to those for the ibuprofen group (p = 0.010, p = 0.018, and p = 0.010, respectively), indicating that those taking the curcumin and those taking the ibuprofen experienced the same benefits. The group taking the NSAIDS did experience more gastrointestinal issues. This suggests that curcumin may offer an alternative to NSAIDS for patients with OA seeking treatment but experiencing negative side effects...This was supported by results from a pilot study showing that a dose of 2 g of curcumin had an analgesic effect in subjects with acute pain but without a diagnosis of OA. At this dose, the activity was higher than that associated with 500 mg of acetaminophen, while a lower dose (1.5 g, 300 mg of curcumin) gave only transient and often inadequate relief of pain, indicative of suboptimal therapeutic plasma concentrations. The analgesic effect of the dose achieved significance only 2 h after administration, similar to that observed for acetaminophen. In contrast, the NSAID was more rapidly acting, with the strongest pain relief being reported one hour after administration but with significant gastrointestinalsymptoms. This supports the use of 2 g (higher than needed for inflammation) curcumin for relief of pain as a potential alternative to NSAIDS."    

- Hewlings, Susan J, and Douglas S Kalman. “Curcumin: A Review of Its Effects on Human Health.” Foods (Basel, Switzerland) vol. 6,10 92. 22 Oct. 2017, doi:10.3390/foods6100092  
"Several studies have shown that curcumin exhibits anti-arthritic effects with improvement in pain and physical function scores. At a dose of 1 g/day for 8–12 weeks, the improvement in osteoarthritic pain and infammation was comparable with that of ibuprofen and diclofenac.
- Turmeric, potion or poison?, Nataly Martini, vol 11, 2019, Journal of Primary Health Care.  
9. Natural pain reliever 
"At a dose of 1 g/day for 8–12 weeks, the improvement in osteoarthritic pain and inflammation was comparable with that of ibuprofen and diclofenac. In another study using a lecithinised formulation to increase bioavailability, 400 mg curcumin was associated with greater analgesic activity than 500 mg paracetamol, while 300 mg provided suboptimal pain relief.
- Turmeric, potion or poison?, Nataly Martini, vol 11, 2019, Journal of Primary Health Care.  

"In a similar randomized placebo-controlled single-blind pilot trial, 20 male healthy, moderately active volunteers were randomized to receive either 1 g curcumin twice daily (200 mg curcumin twice a day ) or a placebo 48 h prior to and 24 h after a downhill running test. Subjects in the curcumin group reported significantly less pain in the right and left anterior thigh. Significantly fewer subjects in the curcumin group had MRI evidence of muscle injury in the posterior or medial compartment of both thighs. Increases in markers of muscle damage and inflammation tended to be lower in the curcumin group, but significant differences were only observed for interleukin-8 at 2 h after exercise. No differences in markers of oxidative stress and muscle histology were observed. These results further support that curcumin may be beneficial to attenuate exercise-induced muscle soreness" 
 - Hewlings, Susan J, and Douglas S Kalman. “Curcumin: A Review of Its Effects on Human Health.” Foods (Basel, Switzerland) vol. 6,10 92. 22 Oct. 2017, doi:10.3390/foods6100092
10. Gastroprotective action, Gut health 
"Gastrointestinal ulcer could be induced by infection of the stomach by a bacterium called H. pylori, by chronic ingestion of NSAIDs, and exogenous substances such as cigarette, alcohol, and fast foods. A dietary natural drug (curcumin) could be used to protector treat the inflammation induced by the ulcer effectors. The biological effect of curcumin to combat these induced pathological disorders is due to its anti-inflammatory and antioxidant activities. Therefore, this review confirmed curcumin as an antiulcer potent agent." 
- Yadav, Santosh Kumar et al. “Turmeric (curcumin) remedies gastroprotective action.” Pharmacognosy reviews vol. 7,13 (2013): 42-6. doi:10.4103/0973-7847.112843

"Curcumin (diferuloylmethane) is the active compound (phytochemical) in the common, bright yellow curry spice, turmeric. Indian, Chinese, and Western herbal medicines traditionally use turmeric, of the ginger family, for conditions such as poor digestion, abdominal pain, and distension. In 1999, the World Health Organization recommended it for treatment of acid reflux, flatulence, and functional dyspepsia, as used in Ayurvedic medicine. 
Ten years ago, the Canadian Society of Intestinal Research, the Gastrointestinal Society’s sister charity, provided funding for Dr. Baljinder Salh’s research into the benefits of curcumin in colon cancer. Salh and his Vancouver team contributed to a building body of evidence that this flavourful spice can help prevent cancerous cells from developing in the colon. 
 A basic research study from India looked at mice with induced colitis and found that curcumin exerts beneficial effects in experimental colitis by mediating the inflammatory processes. Therefore, it may be useful in the treatment of inflammatory bowel disease.
 A clinical study from the UK involving 207 irritable bowel syndrome patients showed improvement in their symptoms after the researchers had them take turmeric tablets. The researchers recommend further, larger, placebo-controlled studies." 

- https://badgut.org/information-centre/health-nutrition/many-benefits-turmeric/
Sub literature: 
1. Moussavi M et al. Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells. Carcinogenesis. 2006;27(8):1634-44. 
2. Ukil I et al. Curcumin, The Major Component of Food Flavour Turmeric, Reduces Mucosal Injury in Trinitrobenzene Sulphonic Acid-Induced Colitis. British Journal of Pharmacology. 2003;139:209-218. doi:10.1038/sj.bjp.0705241 
3. Bundy R et al. Turmeric Extract May Improve Irritable Bowel Syndrome Symptomology in Otherwise Healthy Adults: A Pilot Study. The Journal Of Alternative And Complementary Medicine. 2004;10(6):1015-1018.
Check out some of 

THE BENEFITS OF CURRY LEAVES (MURRAYA KOENIGII/MK) 

1. Anti-bacterial 
In the present investigation, the oil was dominated by the linalool (32.83%) and monoterpenic ester linalyl acetate (16%) but the previous report of same plant species growing in Bangladesh dominated by the 3-carene (54.22%) and linalool (0.19%) was present as minor compound (Chowdhury et al., 2008). Other major components are Elemol (7.44%), Geranyl acetate (6.18%), Myrcene (6.12%), Allo-Ocimene (5.02%), α-Terpineol (4.9%), (E)-β-Ocimene (3.68%), Neryl acetate (3.45%) respectively. Linalool is reported to possess antibacterial, insect-repelling and toxic activities (Cardile et al., 2009 ▶).
- Rajendran, M. P., Pallaiyan, B. B., & Selvaraj, N. (2014). Chemical composition, antibacterial and antioxidant profile of essential oil from Murraya koenigii (L.) leaves. Avicenna journal of phytomedicine, 4(3), 200–214.
2. Antioxidants
"The antioxidant activity of curry leaf is attributed to mahanimbine, murrayanol and mahanine (Tachibana et al. 2001; Ningappa et al. 2008). Antioxidant effect of curry leaf powder in chicken and goat meat products has also been reported (Biswas et al. 2006; Das et al. 2011)...Table 1 shows the antioxidant properties of curry leaves and fenugreek extracts. Curry leaves had a significantly (P < 0.05) higher phenolic content...The reducing power was significantly (P < 0.05) higher in curry leaves than fenugreek. Palaniswamy (2001) reported that water-ethanol extract of curry leaves comprised of a high polyphenolic content and the antioxidant activity may be the result of the synergistic action of all the components, rather than of a single entity of the extract...Similar studies have reported that natural antioxidants are involved in the termination of free radical reactions and exhibit reducing capacity (Wang et al. 2003). The reducing capacity might be due to their hydrogen donating ability (Shimada et al. 1992).
 - Devatkal, Suresh K et al. “Comparative antioxidant effect of aqueous extracts of curry leaves, fenugreek leaves and butylated hydroxytoluene in raw chicken patties.” Journal of food science and technology vol. 49,6 (2012): 781-5. doi:10.1007/s13197-011-0511-0 
3. De-stress potential, Pain-relieving properties
De-stress: 
"In the present investigation, the oil was dominated by the linalool (32.83%) and monoterpenic ester linalyl acetate (16%) but the previous report of same plant species growing in Bangladesh dominated by the 3-carene (54.22%) and linalool (0.19%) was present as minor compound (Chowdhury et al., 2008). Other major components are Elemol (7.44%), Geranyl acetate (6.18%), Myrcene (6.12%), Allo-Ocimene (5.02%), α-Terpineol (4.9%), (E)-β-Ocimene (3.68%), Neryl acetate (3.45%) respectively... One of the research reports was found that inhaling linalool can reduce stress in lab rats so the findings could form the basis of new blood tests for identifying fragrances that can soothe stress (Nakamura et al., 2009 ▶)." 
- Rajendran, M. P., Pallaiyan, B. B., & Selvaraj, N. (2014). Chemical composition, antibacterial and antioxidant profile of essential oil from Murraya koenigii (L.) leaves. Avicenna journal of phytomedicine, 4(3), 200–214.

Pain relief: 
Our results demonstrated that MK significantly (p < 0.01) inhibited the pain thresholds induced by formalin and acetic acid in a dose-dependent manner. MK also significantly (p < 0.01) suppressed glutamate-induced pain. Moreover, pretreatment with glibenclamide (an ATP-sensitive potassium channel blocker) at 10 mg/kg significantly (p < 0.05) reversed the MK-mediated antinociception. These revealed that MK might have the potential to interact with glutamatergic system and the ATP-sensitive potassium channels to exhibit its antinociceptive activities. Therefore, our results strongly support the antinociceptive effects of M. koenigii leaves and provide scientific basis of their analgesic uses in the traditional medicine.
- Sharmin Ani N, Chakraborty S, Moniruzzaman M. The Methanolic Extract from Murraya koenigii L. Inhibits Glutamate-Induced Pain and Involves ATP-Sensitive K+ Channel as Antinociceptive Mechanism. Adv Pharmacol Sci. 2016;2016:3790860. doi:10.1155/2016/3790860
4. Neuro-protective properties 
"The MKA improved the level of protective antioxidants such as glutathione peroxidase (GPx), reduced glutathione (GSH), glutathione reductase (GRD), superoxide dismutase (SOD) and catalase (CAT) in brain homogenate at higher doses (20 and 40 mg/kg, p.o.). Moreover, a dose dependent decline was noted in lipid peroxidation (LPO) and the nitric oxide assay (NO) at all doses of MKA (10, 20 and 40 mg/kg, p.o.). Interestingly, significant progress was noted with the supplementation of MKA by an improvement of the acetylcholine (ACh) levels and a reduction in the acetylcholinesterase (AChE) activity in aged mouse brain. In addition, a significant elevation of serum albumin (ALBU), alkaline phosphatase (ALP), alanine transaminase (ALT), aspartate transaminase (AST) and total protein as well as a decline in creatinine, total cholesterol, urea nitrogen and glucose levels with MKA also ameliorated the hepatic and renal functions in normal ageing process. The results showed the possible utility of Murraya koenigii leaves in neuroprotection against neurodegenerative disorders such as Alzheimer's disease.
- Mani V, Ramasamy K, Ahmad A, Wahab SN, Jaafar SM, Kek TL, Salleh MZ, Majeed AB. Effects of the total alkaloidal extract of Murraya koenigii leaf on oxidative stress and cholinergic transmission in aged mice. Phytother Res. 2013 Jan;27(1):46-53. doi: 10.1002/ptr.4676. Epub 2012 Mar 23. PMID: 22447662. 
 
In other words "A study in mice found that oral treatment with high doses of curry leaf extract improved levels of brain-protecting antioxidants, including glutathione peroxidase (GPx), glutathione reductase (GRD), and superoxide dismutase (SOD), in brain cells. The extract also reduced the amount of oxidative damage in brain cells, as well as enzymes associated with Alzheimer’s disease progression
- https://www.healthline.com/nutrition/curry-leaves-benefits#3.-May-have-neuroprotective-properties 

"MKA (20 and 30 mg/kg, p.o.) showed significant improvement in memory scores of young and aged mice. Furthermore, the same doses of MKA reversed the amnesia induced by scopolamine (0.4 mg/kg, i.p.) and diazepam (1 mg/kg, i.p.). Interestingly, the brain cholinesterase activity was also reduced significantly by total alkaloidal extract of M. koenigii leaves. The IC50 value of MKA against BACE1 was 1.7 μg/mL. In conclusion, this study indicates MKA to be a useful remedy in the management of Alzheimer's disease and dementia."
- Mani V, Ramasamy K, Ahmad A, Parle M, Shah SA, Majeed AB. Protective effects of total alkaloidal extract from Murraya koenigii leaves on experimentally induced dementia. Food Chem Toxicol. 2012 Mar;50(3-4):1036-44. doi: 10.1016/j.fct.2011.11.037. Epub 2011 Nov 28. PMID: 22142688.
5. Heart diseases, Diabetes 
"The dichloromethane (MKD) and ethyl acetate (MKE) extracts of Murraya koenigii leaves significantly reduced the body weight gain, plasma total cholesterol (TC) and triglyceride (TG) levels significantly when given orally at a dose of 300 mg/kg/day to the high fat diet (HFD) induced obese rats for 2 weeks."
- Birari R, Javia V, Bhutani KK. Antiobesity and lipid lowering effects of Murraya koenigii (L.) Spreng leaves extracts and mahanimbine on high fat diet induced obese rats. Fitoterapia. 2010 Dec;81(8):1129-33. doi: 10.1016/j.fitote.2010.07.013. Epub 2010 Jul 23. PMID: 20655993.

"Murraya koenigii (curry leaves), against progression of high-fat diet (HFD)-induced metabolic complications in mice (male and female). Mahanimbine at 2 mg/kg (HFD + LD) and 4 mg/kg (HFD + HD) of body weight was administered daily along with HFD feeding for 12 weeks... Mahanimbine prevented HFD-induced hyperlipidemia and fat accumulation in adipose tissue and liver along with the restricted progression of systemic inflammation and oxidative stress. Moreover, mahanimbine treatment improved glucose clearance and upregulated the expression of insulin responsive genes in liver and adipose tissue. Male and female mice showed different traits in development of HFD-induced metabolic disturbances; however, mahanimbine treatment exerted similar effects in both the sexes. In addition, mahanimbine lowered the absorption of dietary fat resulting in dietary fat excretion. In conclusion, daily consumption of mahanimbine and thereby curry leaves may alleviate development of HFD-induced metabolic alterations.
- Jagtap S, Khare P, Mangal P, Kondepudi KK, Bishnoi M, Bhutani KK. Effect of mahanimbine, an alkaloid from curry leaves, on high-fat diet-induced adiposity, insulin resistance, and inflammatory alterations. Biofactors. 2017 Mar;43(2):220-231. doi: 10.1002/biof.1333. Epub 2016 Sep 24. PMID: 27663177.

"The generation of oxygen derived free radicals in diabetic condition is the leading cause of the development of diabetic neuro-logical complications like neuropathic pain and depression. Thus the drug which has antioxidant property may be used for the prevention of diabetic complications. Previous studies have confirmed the presence of antioxidant carbazole alkaloids in leaves of Murraya koenigii. Thus these constituents i.e. carbazole alkaloids may probably be responsible for the prevention of the neuropathic pain in the present study...The plant has the potential of offering a better choice in the curative therapy in the progression of diabetic neuropathy which can be extracted by either preventing the nerve damage or controlling of symptomatic pain along with good glycemic control. Therfore, it could be helpful in treating the diabetic patient having the complication like diabetic neuropathy."  
- Tembhurne SV, Sakarkar DM. Influence of Murraya koenigii on experimental model of diabetes and progression of neuropathic pain. Res Pharm Sci. 2010 Jan;5(1):41-7. PMID: 21589767; PMCID: PMC3093092.

"Results of chronic treatments with MKL (300 and 500 mg/kg p.o) indicates decreasing the blood glucose levels at 30th and 60th day while the more significant (P< 0.01) effect took place only at 60th day (Fig. 1). The hypoglycemic effect of MKL was comparable to standard glibenclamide as antidiabetic agent." 
- Tembhurne SV, Sakarkar DM. Influence of Murraya koenigii on experimental model of diabetes and progression of neuropathic pain. Res Pharm Sci. 2010 Jan;5(1):41-7. PMID: 21589767; PMCID: PMC3093092.
6. Weight Loss
"The dichloromethane (MKD) and ethyl acetate (MKE) extracts of Murraya koenigii leaves significantly reduced the body weight gain, plasma total cholesterol (TC) and triglyceride (TG) levels significantly when given orally at a dose of 300 mg/kg/day to the high fat diet (HFD) induced obese rats for 2 weeks... Mahanimbine (1) when given orally (30 mg/kg/day) also significantly lowered the body weight gain as well as plasma TC and TG levels. These findings demonstrate the excellent pharmacological potential of mahanimbine to prevent obesity." 
- Birari R, Javia V, Bhutani KK. Antiobesity and lipid lowering effects of Murraya koenigii (L.) Spreng leaves extracts and mahanimbine on high fat diet induced obese rats. Fitoterapia. 2010 Dec;81(8):1129-33. doi: 10.1016/j.fitote.2010.07.013. Epub 2010 Jul 23. PMID: 20655993.

"In addition, mahanimbine lowered the absorption of dietary fat resulting in dietary fat excretion."
- Jagtap S, Khare P, Mangal P, Kondepudi KK, Bishnoi M, Bhutani KK. Effect of mahanimbine, an alkaloid from curry leaves, on high-fat diet-induced adiposity, insulin resistance, and inflammatory alterations. Biofactors. 2017 Mar;43(2):220-231. doi: 10.1002/biof.1333. Epub 2016 Sep 24. PMID: 27663177.
7. Anti-inflammatory
"Murraya koenigii (curry leaves), against progression of high-fat diet (HFD)-induced metabolic complications in mice (male and female). Mahanimbine at 2 mg/kg (HFD + LD) and 4 mg/kg (HFD + HD) of body weight was administered daily along with HFD feeding for 12 weeks... Mahanimbine prevented HFD-induced hyperlipidemia and fat accumulation in adipose tissue and liver along with the restricted progression of systemic inflammation and oxidative stress.
Jagtap S, Khare P, Mangal P, Kondepudi KK, Bishnoi M, Bhutani KK. Effect of mahanimbine, an alkaloid from curry leaves, on high-fat diet-induced adiposity, insulin resistance, and inflammatory alterations. Biofactors. 2017 Mar;43(2):220-231. doi: 10.1002/biof.1333. Epub 2016 Sep 24. PMID: 27663177. 

"Methods: Herein, cytotoxic activity of MK was first tested on 4T1 cells in vitroby MTT assay. Then, in vivo chemopreventive study was conducted where mice were fed with extracts prior to and after inducing the tumor (inoculation). Tumor size was monitored post-4T1 inoculation. At the end of experiment, histopathology of tumor sections, T cell immunophenotyping, tumor nitric oxide level, serum cytokine level and qPCR analysis on expression of iNOS, iCAM, NF-kB and c-MYC were performed. Results: MK reduced the tumors' size and lung metastasis aside from inhibited the viability of 4T1 cells in vitro. Furthermore, it decreased the level of nitric oxide and inflammation-related cytokines and genes, including iNOS, iCAM, NF-kB and c-MYC. Conclusion: The results propose that, MK managed to inhibit the progression of tumor via immunostimulatory effect and inflammatory reaction within the tumor samples. This suggests that MKconsumption could be a savior in the search of new chemopreventive agents." - Yeap SK, Abu N, Mohamad NE, Beh BK, Ho WY, Ebrahimi S, Yusof HM, Ky H, Tan SW, Alitheen NB. Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice. BMC Complement Altern Med. 2015 Sep 4;15:306. doi: 10.1186/s12906-015-0832-z. PMID: 26335427; PMCID: PMC4559205.
8. Anti-cancer affects
"Methods: Herein, cytotoxic activity of MK was first tested on 4T1 cells in vitroby MTT assay. Then, in vivo chemopreventive study was conducted where mice were fed with extracts prior to and after inducing the tumor (inoculation). Tumor size was monitored post-4T1 inoculation. At the end of experiment, histopathology of tumor sections, T cell immunophenotyping, tumor nitric oxide level, serum cytokine level and qPCR analysis on expression of iNOS, iCAM, NF-kB and c-MYC were performed. Results: MK reduced the tumors' size and lung metastasis aside from inhibited the viability of 4T1 cells in vitro. Furthermore, it decreased the level of nitric oxide and inflammation-related cytokines and genes, including iNOS, iCAM, NF-kB and c-MYC. Conclusion: The results propose that, MK managed to inhibit the progression of tumor via immunostimulatory effect and inflammatory reaction within the tumor samples. This suggests that MKconsumption could be a savior in the search of new chemopreventive agents.
- Yeap SK, Abu N, Mohamad NE, Beh BK, Ho WY, Ebrahimi S, Yusof HM, Ky H, Tan SW, Alitheen NB. Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice. BMC Complement Altern Med. 2015 Sep 4;15:306. doi: 10.1186/s12906-015-0832-z. PMID: 26335427; PMCID: PMC4559205.

"One of the more significant findings to emerge from this study is that the curry leaf extracts exhibited a promising anticancer activity on MDA-MB-231 human breast cancer cell line. [Mahenine, a carbazole alkaloid isolated from curry leaf, has been reported to induce apoptosis in human myeloid HL-60 cancer cells by downregulating cell survival factors and disrupting the cell cycle progression. Antitumorogenic activity of a curry leaf extract (stem bark) against MCF-7 breast cancer cells has been reported by Handral et al.]
The extracts contained substantial amounts of effective flavonoid compounds such as myricetin, epicatechin, and quercetin which showed potency in the growth inhibition of breast cancer cells."
- Ghasemzadeh A, Jaafar HZ, Rahmat A, Devarajan T. Evaluation of Bioactive Compounds, Pharmaceutical Quality, and Anticancer Activity of Curry Leaf (Murraya koenigii L.). Evid Based Complement Alternat Med. 2014;2014:873803. doi:10.1155/2014/873803

"Previously, girinimbine, a carbazole alkaloid from the roots of M. koenigii, was found to inhibit cancer cell proliferation and promote apoptosis in human cancer cell lines. In our recent study, we found that girinimbine inhibited angiogenesis both in vivo and in vitro. We subsequently evaluated the effects of girinimbine on the induction of apoptosis* in a human colorectal adenocarcinoma cell line (HT-29) and in a zebrafish embryo model, as well as inhibition of inflammation in murine monocyte macrophage cells (RAW 264.7) and in mice. 
* Induction of apoptosis is a desired outcome of anticancer therapy"
- Iman V, Mohan S, Abdelwahab SI, et al. Anticancer and anti-inflammatory activities of girinimbine isolated from Murraya koenigii. Drug Des Devel Ther. 2016;11:103-121. Published 2016 Dec 28. doi:10.2147/DDDT.S115135
Check out some of 

THE BENEFITS OF FLAX SEEDS

1. Rich in Alpha-linolenic acid or ALA (a omega 3 plant based fatty acid) and nutrients 
"Preventing the occurrence of cardiovascular disease (CVD) with nutritional interventions is a therapeutic strategy that may warrant greater research attention. The increased use of omega (ω)-3 fatty acids is a powerful example of one such nutritional strategy that may produce significant cardiovascular benefits. Marine food products have provided the traditional dietary sources of ω-3 fatty acids. Flaxseed is an alternative to marine products. It is one of the richest sources of the plant-based ω-3 fatty acid, alpha-linolenic acid (ALA). Based on the results of clinical trials, epidemiological investigations and experimental studies, ingestion of ALA has been suggested to have a positive impact on CVD. Because of its high ALA content, the use of flaxseed has been advocated to combat CVD. The purpose of the present review was to identify the known cardiovascular effects of flaxseed and ALA and, just as importantly, what is presently unknown."
- Rodriguez-Leyva D, Dupasquier CM, McCullough R, Pierce GN. The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid. Can J Cardiol. 2010 Nov;26(9):489-96. doi: 10.1016/s0828-282x(10)70455-4. PMID: 21076723; PMCID: PMC2989356.

"ALA is one of the essential polyunsaturated fatty acid and reported to exhibit anti-inflammatory, anti-thrombotic and anti-arrhythmic properties (Simopoulos 1999). Nutritionists all over the world suggest incorporation of omega 3 fatty acid sources in the diet. Flaxseed serves as the best omega 3 fatty acid source to the non-fish eaters." 
- Rodriguez-Leyva D, Dupasquier CM, McCullough R, Pierce GN. The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid. Can J Cardiol. 2010 Nov;26(9):489-96. doi: 10.1016/s0828-282x(10)70455-4. PMID: 21076723; PMCID: PMC2989356.

It serves as a good source of minerals especially, phosphorous (650 mg/100 g), magnesium (350–431 mg/100 g), calcium (236–250 mg/100 g) and has very low amount of sodium (27 mg/100 g) (Morris 2007). It contains highest amount of potassium 5600–9200 mg/kg among various foods and high potassium intake is inversely related to blood platelet aggregation, free radicals in blood and stroke incidence (Carter 1993). Flaxseed contains small amounts of water-soluble and fat-soluble vitamins. Vitamin E is present as γ-tocopherol, amounting to 39.5 mg/100 g. γ-tocopherol is an antioxidant providing protection to cell proteins and fat from oxidation; promotes sodium excretion in urine, which may help in lowering of blood pressure and heart disease risks and Alzheimer disease (Morris et al. 2005; Morris 2007)."
- Rodriguez-Leyva D, Dupasquier CM, McCullough R, Pierce GN. The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid. Can J Cardiol. 2010 Nov;26(9):489-96. doi: 10.1016/s0828-282x(10)70455-4. PMID: 21076723; PMCID: PMC2989356.
2. Reduce cancer risk, Anti-oxadive properties 
"Flaxseeds contain a good amount of phenolic compounds. These phenolic compounds are well known for anticancer and anti-oxidative properties." 
Kajla P, Sharma A, Sood DR. Flaxseed-a potential functional food source. J Food Sci Technol. 2015;52(4):1857-1871. doi:10.1007/s13197-014-1293-y

"Flaxseeds contains small amounts of water-soluble and fat-soluble vitamins. Vitamin E is present as γ-tocopherol, amounting to 39.5 mg/100 g. γ-tocopherol is an antioxidant providing protection to cell proteins and fat from oxidation."
Kajla P, Sharma A, Sood DR. Flaxseed-a potential functional food source. J Food Sci Technol. 2015;52(4):1857-1871. doi:10.1007/s13197-014-1293-y

"Flaxseeds contains about 75–800 times more lignans than cereal grains, legumes, fruits and vegetables (Mazur et al. 2000; Meagher and Beecher 2000; Murphy and Hendrich 2002; Hosseinian and Beta 2009)...Anticancer activity of lignans is attributed to its ability to scavenge hydroxyl free radicals (Prasad 1997; Hu et al. 2007; Sok et al. 2009)...Flaxseed lignans behaviour depends on biological levels of estrogen hormone. At normal levels of estrogen, it exhibit antagonistic activity, but in postmenopausal phase when estrogen level is low, flaxseed lignans acts as weak estrogen (Sok et al. 2009; Toure and Xueming 2010; Saini et al. 2010)." 
Kajla P, Sharma A, Sood DR. Flaxseed-a potential functional food source. J Food Sci Technol. 2015;52(4):1857-1871. doi:10.1007/s13197-014-1293-y

Flaxseed lignans play an important role in preventing various types of cancer specially the hormone sensitive ones. Flax lignans are reported to have antioxidant property which presumably is the main reason of the anticancer activity (Schweigerer et al. 1992; Prasad 1997)... Various clinical studies imply that lignans prevent breast cancer by balancing the hormonal mechanisms. The lignans inhibit the aromatase activity in adipose tissue resulting in the circulation of estrogen (Sturgeon et al. 2008; Adlercreutz et al. 1993). In postmenopausal women, lignans act as weak estrogens, while at normal estrogen levels, lignans act as estrogen antagonists (Wang et al. 1994; Hutchins and Slavin 2003). Dietary flaxseed moderately lowers the serum levels of steroid sex hormones which are implicated in development of breast cancer in obese postmenopausal women (Sturgeon et al. 2008). 
Kajla P, Sharma A, Sood DR. Flaxseed-a potential functional food source. J Food Sci Technol. 2015;52(4):1857-1871. doi:10.1007/s13197-014-1293-y
3. Neuroprotective 
Depression 
"Several clinical studies showed that EPA and DHA play a major role in reducing depression symptoms. During depression or stress proinflammatory cytokines such as TNF-α, interferon gamma etc. are produced. Increased of n-6 fatty acid to n-3 fatty acid ratio may lead to the production of proinflammatory cytokines which causes depression and mood swings in elderly persons (Maes et al. ; Tiemeier et al. ; Locke and Stoll )."
Kajla P, Sharma A, Sood DR. Flaxseed-a potential functional food source. J Food Sci Technol. 2015;52(4):1857-1871. doi:10.1007/s13197-014-1293-y

"A longitudinal study of 50,000 women found that increased intake of ALA reduced depressive symptom. Earlier studies showed similar results. In normal mice, ALA treatment (given intravenously or in the diet) exerted an antidepressant effect. This effect was associated with increased synaptogenesis and an increase in BDNF mRNA levels in brain. Evidence has shown that antidepressant drugs enhance the activation of TrkB receptors, the high affinity receptor that binds BDNF and is a key event in exerting antidepressant properties; BDNF has been implicated in mediating the antidepressant effects in brain." 
- Blondeau N, Lipsky RH, Bourourou M, Duncan MW, Gorelick PB, Marini AM. Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic? Biomed Res Int. 2015;2015:519830. doi: 10.1155/2015/519830. Epub 2015 Feb 19. PMID: 25789320; PMCID: PMC4350958.

Stroke
"We and others have identified ALA as a potential nutraceutical to protect the brain from stroke, characterized by its pleiotropic effects in neuroprotection, vasodilation of brain arteries, and neuroplasticity. This review highlights how chronic administration of ALA protects against rodent models of hypoxic-ischemic injury and exerts an anti-depressant-like activity, effects that likely involve multiple mechanisms in brain, and may be applied in stroke prevention. One major effect may be through an increase in mature brain-derived neurotrophic factor (BDNF), a widely expressed protein in brain that plays critical roles in neuronal maintenance, and learning and memory." 
- Blondeau N, Lipsky RH, Bourourou M, Duncan MW, Gorelick PB, Marini AM. Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic? Biomed Res Int. 2015;2015:519830. doi: 10.1155/2015/519830. Epub 2015 Feb 19. PMID: 25789320; PMCID: PMC4350958.

"In adult men, serum levels of ALA were independently associated with a 37% reduction in stroke risk. Also, the higher the intake of α-linolenic acid, the lower the prevalence of a carotid plaque, and similar results were reported in mice. ALA activates a neuronal background rectifying potassium channel leading to membrane hyperpolarization which in turn increases the magnesium block of the calcium channel associated with NMDA receptors which play a predominant role in mediating glutamate-mediated excitotoxic neuronal cell death. In this rodent model of global ischemia where hippocampal pyramidal neuronal death is mainly driven by glutamate excitotoxicity, we found that ALA exerted a profound protective effect that was more pronounced and reproducible than with EPA and DHA." 
- Blondeau N, Lipsky RH, Bourourou M, Duncan MW, Gorelick PB, Marini AM. Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic? Biomed Res Int. 2015;2015:519830. doi: 10.1155/2015/519830. Epub 2015 Feb 19. PMID: 25789320; PMCID: PMC4350958.

"Additional studies in rodents revealed an essential role for the transcription factor, nuclear factor kappaB, in the ability of ALA to protect neurons against ischemia and to induce tolerance, a phenomenon where neurons become resistant to a stressful environment such as ischemia. ALA was shown to increase levels of brain-derived neurotrophic factor (BDNF), a widely distributed protein that in the brain carries out diverse functions, including neuronal maintenance, learning and memory, neuronal survival, and neurogenesis. Other proteins, such as HSP70, a heat shock protein, which acts as a protein chaperone, also have roles in regulating programmed cell death (i.e., apoptosis)."
- Blondeau N, Lipsky RH, Bourourou M, Duncan MW, Gorelick PB, Marini AM. Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic? Biomed Res Int. 2015;2015:519830. doi: 10.1155/2015/519830. Epub 2015 Feb 19. PMID: 25789320; PMCID: PMC4350958.

"Of the known gene targets of ALA, BDNF shows promise as a therapy for stroke. In many studies, BDNF has been shown to reduce infarct size and improve outcome (see and the references therein) whereas blocking endogenous BDNF worsens ischemia. Administration of BDNF via the intravenous route as well as the intracerebroventricular route reduced infarct size and improved outcome in the transient middle cerebral artery occlusion model of stroke. However, in humans, anticipated pharmacokinetic challenges make it difficult to develop BDNF itself as a therapy to the clinic... To this end, chronic ALA treatment increases BDNF mRNA and protein levels in the cortex and hippocampus, two brain regions that are susceptible to ischemia but are also involved in plasticity responses. ALA increases neurogenesis, synaptogenesis, and synaptic function in the rodent brain. The ability to increase neurogenesis in the brain is critical because it has been shown that neural stem cells improve neurological function in stroke. Neural stem cells can modulate the ischemic environment via the upregulation of survival-promoting/neurotrophic factors such as BDNF and/or by restoring neurotransmitter function by integrating in existing networks and improving network circuitry. Taken together, these findings indicate that ALA induces tolerance and reduces infarct size in animal models of stroke.
- Blondeau N, Lipsky RH, Bourourou M, Duncan MW, Gorelick PB, Marini AM. Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic? Biomed Res Int. 2015;2015:519830. doi: 10.1155/2015/519830. Epub 2015 Feb 19. PMID: 25789320; PMCID: PMC4350958.
5. Improves cholesterol & the heart, Inflammation of the arteries
"Rabbits were randomly assigned to receive either a regular diet for 12 wk (group I) or a 1% cholesterol-supplemented diet for 4 wk followed by a regular diet for 8 wk (group II). The remaining experimental animals were treated as in group II but were fed for an additional 14 wk with either a regular diet (group III) or a 10% flaxseed-supplemented diet (group IV). Animals in group II showed clear evidence of plaque growth stabilization. Their vessels also exhibited significantly lower norepinephrine-induced contraction and an impaired relaxation response to acetylcholine compared with animals in group I. Dietary flaxseed supplementation resulted in a significant ≈40% reduction in plaque formation (P = 0.033). Animals in both groups II and III displayed improved contraction and endothelium-dependent vessel relaxation. Dietary flaxseed is a valuable strategy to accelerate the regression of atherosclerotic plaques; however, flaxseed intervention did not demonstrate a clear beneficial effect on the vessel contractile response and endothelium-dependent vasorelaxation." 
- Francis AA, Deniset JF, Austria JA, LaValleé RK, Maddaford GG, Hedley TE, Dibrov E, Pierce GN. Effects of dietary flaxseed on atherosclerotic plaque regression. Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12):H1743-51. doi: 10.1152/ajpheart.00606.2012. Epub 2013 Apr 12. PMID: 23585134.

"Preventing the occurrence of cardiovascular disease (CVD) with nutritional interventions is a therapeutic strategy that may warrant greater research attention. The increased use of omega (ω)-3 fatty acids is a powerful example of one such nutritional strategy that may produce significant cardiovascular benefits. Marine food products have provided the traditional dietary sources of ω-3 fatty acids. Flaxseed is an alternative to marine products. It is one of the richest sources of the plant-based ω-3 fatty acid, alpha-linolenic acid (ALA). Based on the results of clinical trials, epidemiological investigations and experimental studies, ingestion of ALA has been suggested to have a positive impact on CVD. Because of its high ALA content, the use of flaxseed has been advocated to combat CVD. The purpose of the present review was to identify the known cardiovascular effects of flaxseed and ALA and, just as importantly, what is presently unknown."
- Rodriguez-Leyva D, Dupasquier CM, McCullough R, Pierce GN. The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid. Can J Cardiol. 2010 Nov;26(9):489-96. doi: 10.1016/s0828-282x(10)70455-4. PMID: 21076723; PMCID: PMC2989356.

"Flaxseed contains small amounts of water-soluble and fat-soluble vitamins. Vitamin E is present as γ-tocopherol, amounting to 39.5 mg/100 g. γ-tocopherol is an antioxidant providing protection to cell proteins and fat from oxidation; promotes sodium excretion in urine, which may help in lowering of blood pressure and heart disease risks and Alzheimer disease (Morris et al. 2005; Morris 2007)."


"Several studies advocated the cholesterol lowering benefits of flaxseed meal (Cunnane et al. 1993; Ridges et al. 2001; Bhathena et al. 2003). A study on hypercholesterolemic rats fed on flaxseed chutney supplemented diet (15 %) revealed significant reduction in LDL cholesterol and total serum cholesterol and no change in HDL cholesterol. In CCl4 intoxicated rats, lipid peroxidation products were neutralized by flaxseed lignans (Shakir and Madhusudan 2007)." 

"Dietary fiber delays gastric emptying, regulate post prandial blood glucose levels and helpful in prevention of constipation (Spiller 1994). Flaxseed fiber plays an important role in lowering the blood glucose levels. Studies demonstrated that insoluble fiber slows down the release of sugar in the blood and thus help in reducing blood glucose levels to great extent (Thakur et al. 2009; Kapoor et al. 2011). Soluble gum of the flaxseed may be helpful in the prevention of cardiovascular diseases by exhibiting hypocholesterolemic effect (Jenkins et al. 1987; Cunnane et al. 1994). Kristensen et al. 2012 studied the effect of differently processed flax fibers on the fat excretion and energy balance. It was observed that flax fiber enriched drink lowered the cholesterol to a large extent as compared to fiber enriched bread. However, the consumption of fiber bread increased the fecal fat excretion and maintained proper energy balance. Studies have shown that the high intake of dietary fibers is beneficial for the prevention of obesity in both men and women (Du et al. 2010)."
- Kajla P, Sharma A, Sood DR. Flaxseed-a potential functional food source. J Food Sci Technol. 2015;52(4):1857-1871. doi:10.1007/s13197-014-1293-y

"Background: Intake of long-chain n-3 fatty acids found in fish is low in many countries worldwide. alpha-Linolenic acid could be a viable cardioprotective alternative to these fatty acids in these countries. 
Methods and results: Cases (n=1819) with a first nonfatal acute myocardial infarction and population-based controls (n=1819) living in Costa Rica matched for age, sex, and area of residence were studied. Fatty acids were assessed by gas chromatography in adipose tissue samples and by a validated food frequency questionnaire specifically designed for this population. Odds ratios and 95% confidence intervals were calculated from multivariate conditional logistic regression models. alpha-Linolenic acid in adipose tissue ranged from 0.36% in the lowest decile to 1.04% in the highest decile. The corresponding median levels of intake were 0.42% and 0.86% energy. Greater alpha-linolenic acid (assessed either in adipose or by questionnaire) was associated with lower risk of myocardial infarction. The odds ratios for nonfatal myocardial infarction for the highest compared with the lowest deciles were 0.41 (95% confidence interval, 0.25 to 0.67) for alpha-linolenic acid in adipose tissue and 0.61 (95% confidence interval, 0.42 to 0.88) for dietary alpha-linolenic acid. The relationship between alpha-linolenic acid and myocardial infarction was nonlinear; risk did not decrease with intakes > approximately 0.65% energy (1.79 g/d). Fish or eicosapentaenoic acid and docosahexaenoic acid intake at the levels found in this population did not modify the observed association.  
Conclusions: Consumption of vegetable oils rich in alpha-linolenic acid could confer important cardiovascular protection. The apparent protective effect of alpha-linolenic acid is most evident among subjects with low intakes." 
- Pan A, Chen M, Chowdhury R, Wu JH, Sun Q, Campos H, Mozaffarian D, Hu FB. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012 Dec;96(6):1262-73. doi: 10.3945/ajcn.112.044040. Epub 2012 Oct 17. PMID: 23076616; PMCID: PMC3497923.

"Background: Prior studies of α-linolenic acid (ALA), a plant-derived omega-3 (n-3) fatty acid, and cardiovascular disease (CVD) risk have generated inconsistent results. 
Objective: We conducted a meta-analysis to summarize the evidence regarding the relation of ALA and CVD risk. 
 Design: We searched multiple electronic databases through January 2012 for studies that reported the association between ALA (assessed as dietary intake or as a biomarker in blood or adipose tissue) and CVD risk in prospective and retrospective studies. We pooled the multivariate-adjusted RRs comparing the top with the bottom tertile of ALA using random-effects meta-analysis, which allowed for between-study heterogeneity. Results: Twenty-seven original studies were identified, including 251,049 individuals and 15,327 CVD events. The overall pooled RR was 0.86 (95% CI: 0.77, 0.97; I² = 71.3%). The association was significant in 13 comparisons that used dietary ALA as the exposure (pooled RR: 0.90; 95% CI: 0.81, 0.99; I² = 49.0%), with similar but nonsignificant trends in 17 comparisons in which ALA biomarkers were used as the exposure (pooled RR: 0.80; 95% CI: 0.63, 1.03; I² = 79.8%). An evaluation of mean participant age, study design (prospective compared with retrospective), exposure assessment (self-reported diet compared with biomarker), and outcome [fatal coronary heart disease (CHD), nonfatal CHD, total CHD, or stroke] showed that none were statistically significant sources of heterogeneity. 
Conclusions: In observational studies, higher ALA exposure is associated with a moderately lower risk of CVD. The results were generally consistent for dietary and biomarker studies but were not statistically significant for biomarker studies. However, the high unexplained heterogeneity highlights the need for additional well-designed observational studies and large randomized clinical trials to evaluate the effects of ALA on CVD."  
Pan A, Chen M, Chowdhury R, Wu JH, Sun Q, Campos H, Mozaffarian D, Hu FB. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012 Dec;96(6):1262-73. doi: 10.3945/ajcn.112.044040. Epub 2012 Oct 17. PMID: 23076616; PMCID: PMC3497923.
6. Lowers blood pressure 
Flaxseed contains small amounts of water-soluble and fat-soluble vitamins. Vitamin E is present as γ-tocopherol, amounting to 39.5 mg/100 g. γ-tocopherol is an antioxidant providing protection to cell proteins and fat from oxidation; promotes sodium excretion in urine, which may help in lowering of blood pressure and heart disease risks and Alzheimer disease (Morris et al. 2005; Morris 2007).
Kajla P, Sharma A, Sood DR. Flaxseed-a potential functional food source. J Food Sci Technol. 2015;52(4):1857-1871. doi:10.1007/s13197-014-1293-y

SECO, SDG also play an important role in reduction of hypercholesterolemia, atherosclerosis, hypertension and diabetes (Prasad 2000, 2004). Daily administration of 100 mg SDG was found to be effective in reducing blood cholesterol and hepatic diseases risk in moderately hypercholesterolemic men (Fukumitsu et al. 2010). 
Kajla P, Sharma A, Sood DR. Flaxseed-a potential functional food source. J Food Sci Technol. 2015;52(4):1857-1871. doi:10.1007/s13197-014-1293-y

"Hypertension is the single largest risk factor attributed to mortality in the world. Medications are the primary treatment for hypertension; however, adherence to drug regimens is low (~50 %). Low adherence may be a contributing factor leading to uncontrolled blood pressure in patients. An effective alternative or complement to medications in managing hypertension is through lifestyle modifications. Adopting a healthy diet is a valuable strategy. A recent, randomized controlled year-long trial observed impressive reductions in blood pressure in patients with hypertension consuming flaxseed daily. Therefore, attention has been garnered for flaxseed as a potentially valuable strategy for the management of hypertension." 
- Caligiuri SP, Edel AL, Aliani M, Pierce GN. Flaxseed for hypertension: implications for blood pressure regulation. Curr Hypertens Rep. 2014 Dec;16(12):499. doi: 10.1007/s11906-014-0499-8. PMID: 25342643.

"In this prospective, double-blinded, placebo-controlled, randomized trial, patients (110 in total) ingested a variety of foods that contained 30 g of milled flaxseed or placebo each day over 6 months. Plasma levels of the ω-3 fatty acid α-linolenic acid and enterolignans increased 2- to 50-fold in the flaxseed-fed group but did not increase significantly in the placebo group. Patient body weights were not significantly different between the 2 groups at any time. SBP was ≈ 10 mm Hg lower, and DBP was ≈ 7 mm Hg lower in the flaxseed group compared with placebo after 6 months. Patients who entered the trial with a SBP ≥ 140 mm Hg at baseline obtained a significant reduction of 15 mm Hg in SBP and 7 mm Hg in DBP from flaxseed ingestion. The antihypertensive effect was achieved selectively in hypertensive patients. Circulating α-linolenic acid levels correlated with SBP and DBP, and lignan levels correlated with changes in DBP. In summary, flaxseed induced one of the most potent antihypertensive effects achieved by a dietary intervention. " 
- Rodriguez-Leyva D, Weighell W, Edel AL, LaVallee R, Dibrov E, Pinneker R, Maddaford TG, Ramjiawan B, Aliani M, Guzman R, Pierce GN. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013 Dec;62(6):1081-9. doi: 10.1161/HYPERTENSIONAHA.113.02094. Epub 2013 Oct 14. PMID: 24126178.
7. Controls blood sugar
"Several functional foods have been shown to possess hypoglycemic and hypolipidemic properties. Flax seed (FS) is a functional food that is rich in omega 3 fatty acids and antioxidants and is low in carbohydrates. In exploratory studies, FS was incorporated in recipes, which resulted in a reduction in the glycemic index of the food items. These observations prompted us to investigate the efficacy of FS supplementation in type 2 diabetics (n = 29). Subjects were assigned to the experimental (n = 18) or the control group (n = 11) on the basis of their desire to participate in the study. The experimental group's diet was supplemented daily with 10 g of FS powder for a period of 1 month. The control group received no supplementation or placebo. During the study, diet and drug intake of the subjects remained unaltered. The efficacy of supplementation with FS was evaluated through a battery of clinico-biochemical parameters. Supplementation with FS reduced fasting blood glucose by 19.7% and glycated hemoglobin by 15.6%. A favorable reduction in total cholesterol (14.3%), triglycerides (17.5%), low-density lipoprotein cholesterol (21.8%), and apolipoprotein B and an increase in high-density lipoprotein cholesterol (11.9%) were also noticed. These observations suggest the therapeutic potential of FS in the management of diabetes mellitus." 
- Mani UV, Mani I, Biswas M, Kumar SN. An open-label study on the effect of flax seed powder (Linum usitatissimum) supplementation in the management of diabetes mellitus. J Diet Suppl. 2011 Sep;8(3):257-65. doi: 10.3109/19390211.2011.593615. Epub 2011 Jul 15. PMID: 22432725.

"Ninety non-insulin dependent menopausal diabetic female subjects free from serious complications were selected and equally divided into three groups, viz. E 1-, E 2 and C. Subjects of group E 1-and E 2 were provided 15g and 20 g of flaxseed powder for a period of two months respectively, while group C was not given any supplementation. Nutrient intake and meno-pausal symptoms of all the subjects were recorded before and after the supplementation period. Results indicate that blood glucose level decreased significantly in the both the experimental groups after the supplementation. It could be due to the presence of fibre in flaxseed which delays blood glucose absorption. After the supplementation period, significant (p≤0.01) decrease in the energy intake was observed in both the experimental groups and it could be due to the presence of fibre in the flaxseed which gives a high satiety value and results in decreased consumption of energy rich foods. It was observed that majority of the subjects were physi-cally inactive and watching TV was most popular way of relaxation among all the subjects. Further, it was observed that meno-pausal symptoms were relieved after supplementation, this decrease could be due to the presence of phytoestrogens in the flaxseed. It can be inferred from the results that improvement in the blood glucose levels and menopausal symptoms of diabetic subjects was observed among the subjects of E 2 group as compared to E 1 group. Hence, this can can be a panacea in counteracting the problems of menopausal diabetic patients."
- Kapoor, Sherry & Sachdeva, Rajbir & Kochhar, Anita. (2011). Efficacy of Flaxseed Supplementation on Nutrient Intake and Other Lifestyle Pattern in Menopausal Diabetic Females. Studies on Ethno-Medicine. 5. 10.1080/09735070.2011.11886403. 
Check out some of 

THE BENEFITS OF BLACK PEPPER 

1. Antioxidants 
"Black pepper holds significant antioxidant activity as 50% inhibition of 13 free radicals can be achieved with 0.43mg. In some earlier studies conducted by Gulçin 14 (2005), it was observed that water and ethanol extracts (75 µg/ml) of black pepper show 15 95.5%, and 93.3% inhibition of lipid-peroxidation, respectively. The inhibition ought to 16 total phenolics content i.e. 54.3 and 42.8µg/mg, respectively. Saxena et al. (2007) 17 reported higher quantities of polypheols i.e 191mg/100g. Determination of antioxidant 18 activity through some In vitro trials generated some conclusive evidences. In this 19 regard, (Kapoor et al., 2009) observed high antioxidant activities of black pepper essential oil and oleoresins as compared to synthetic antioxidants. Likewise, Su et al. (2007) indicated that black pepper is a potential dietary source of natural antioxidants. Therefore, presence of these functional ingredients in black pepper makes it a strong candidate to ameliorate oxidative stress (Mittal and Gupta, 2000). Gulçin (2005) attributed these actions to its strong hydrogen-donating ability, metal chelating, and effectiveness to scavenge free radicals."
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"Vijayakumar et al. (2004) reported that supplementation of black pepper/piperine lowered oxidative damage and modulated the enzyme systems functioning in the body (Vijayakumar and Nalini, 2006). Rauscher et al. (2007) used diabetes mellitus induction as a model of oxidative damage and application of piperine @ 10mg/kg/day i.p. reversed the diabetes mediated changes in Sprague Dawley rats. The effects are attributed to presence of antioxidants that further results in reduced LDL-oxidation via modulation of prostaglandins and leukotrienes synthesis (Srinivasan, 2005b)."
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"Hamsters were classified into eight groups: a normal control, atherogenic control and six other experimental groups (fed atherogenic diet supplemented with different doses of P. nigrum, P. guineense and P. umbellatum (1 and 0.25 g/kg) for 12 weeks. At the end of the feeding period the heart, liver and kidney from each group were analyzed for lipid profile and antioxidant enzymes activities. Atherogenic diet induced a significant (P<0.001) increase in the lipid profile across the board and equally significantly altered the antioxidant enzyme activities. Supplementation with Piper species significantly inhibited the alteration effect of atherogenic diet on the lipid profile and antioxidant enzymes activities. The Piper extracts may possess an antioxidant protective role against atherogenic diet induced oxidative stress in cardiac, hepatic and renal tissues." 
- Agbor GA, Akinfiresoye L, Sortino J, Johnson R, Vinson JA. Piper species protect cardiac, hepatic and renal antioxidant status of atherogenic diet fed hamsters. Food Chem. 2012 Oct 1;134(3):1354-9. doi: 10.1016/j.foodchem.2012.03.030. Epub 2012 Mar 23. PMID: 25005953.
2. Anti-inflammatory
"Eventually, anti-inflammatory activities of black pepper are reported for the first time 26 some two decades ago. Mujumdar et al. (1990) indicated that piperine mitigate the acute 27 inflammatory process, through stimulating the pituitary adrenal axis. Later, Bang et al. 28 (2009) strengthened the anti-inflammatory activities of piperine (20 & 100 mg/kg/day) 29 through some in vitro trials. They postulated that inhibition of interlukon (IL6), matrix 30 metalloproteinase (MMPs), prostaglandin E2 (PGE2), and activator protein 1 are possible routes for their said properties. Recently, Sabina et al. (2011) reported that piperine (50/100ug/ml) suppressed the level of β-glucuronidase and lactate dehydrogenase in dose-dependent manner. Piperine along with some other components can inhibit the expression of enzymes like 5-lipoxygenase and COX-1 that are responsible for leukotriene and prostaglandin biosynthesis. These effects collectively are valuable to prevent degenerative disorders like rheumatoid arthritis too (Stohr et al., 2001; Lee et al., 2008)."
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"Objectives: This study aimed to investigate the effect of piperine on airway hyperresponsiveness, pulmonary eosinophilic infiltration, various immune cell phenotypes, Th2 cytokine production, immunoglobulin E and histamine production in a murine model of asthma. Methods: Asthma was induced in Balb/c mice by ovalbumin sensitization and inhalation. Piperine (4.5 and 2.25 mg/kg) was orally administered 5 times a week for 8 weeks. At 1 day after the last ovalbumin exposure, airway hyperresponsiveness was determined and samples of bronchoalveolar lavage fluid, lung cells and serum were collected for further analysis. Key findings: Piperine-treated groups had suppressed eosinophil infiltration, allergic airway inflammation and airway hyperresponsiveness, and these occurred by suppression of the production of interleukin-4, interleukin-5, immunoglobulin E and histamine. Moreover, polymerase chain reaction products for thymus and activation regulated chemokine from lung cell RNA preparations were decreased in the piperine-treated group compared with control groups, although transforming growth factor-beta products were increased in the piperine-treated group. Conclusions: The results suggest that the therapeutic mechanism by which piperine effectively treats asthma is based on a reduction of Th2 cytokines (interleukin-4, interleukin-5), eosinophil infiltration, and by marked reduction of thymus and activation regulated chemokine, eotaxin-2 and interleukin-13 mRNA expression (especially transcription of nuclear factor-kappaB dependent genes) in lung tissue, as well as reduced interleukin-4, interleukin-5 and eotaxin levels in bronchoalveolar lavage fluid, and histamine and ovalbumin-specific immunoglobulin E production in serum." - Kim SH, Lee YC. Piperine inhibits eosinophil infiltration and airway hyperresponsiveness by suppressing T cell activity and Th2 cytokine production in the ovalbumin-induced asthma model. J Pharm Pharmacol. 2009 Mar;61(3):353-9. doi: 10.1211/jpp/61.03.0010. PMID: 19222908.

"Context: Allergic rhinitis (AR) is a global health problem that affects a large number of population. Piperine (PIP) has been reported to exhibit anti-inflammatory, anti-histaminic, and immunomodulatory activities; however, its antiallergic profile has not been studied. Objective: The objective of the study was to investigate the antiallergic potential of PIP in ova-albumin (OVA)-induced AR, mast cell degranulation (MSD), and OVA-induced paw edema. 
Materials and methods: Mice were sensitized with OVA alternately on 1, 3, 5, 7, 9, 11, and 13th day. They were treated with either vehicle, PIP (10, 20, and 40 mg/kg, p.o.), or montelukast (10 mg/kg, p.o.) from the 14th to 20th day. On the 21st day, intranasal (OVA: 5% µl) challenge was done. Animals were evaluated for physiological parameters, biochemical parameters, spleen weight, expression of interleukins (IL-6 and IL-1β), and immunoglobin-E (IgE). Histopathology of nasal mucosa, lungs, and spleen was carried out. MSD and paw edema studies were made to understand the mechanism of action. 
Results: PIP (10, 20, and 40 mg/kg, p.o.) showed a significant dose-dependent protection with respect to nasal rubbing, redness of nose, and sneezing (p < 0.001) following nasal challenge. PIP dose dependently reduced histamine, NO concentration (p < 0.001), as well as reduced expression of IL-6, IL-1β, and IgE (p < 0.001) as compared with the control group. Histopathology showed inhibition of infiltration of eosinophils and hyperplasia. It dose dependently reduced MSD and paw edema (p < 0.001). 
Discussion and conclusion: PIP acts by mast cell-stabilizing activity, exhibits immunomodulatory and anti-inflammatory activity, thereby providing an effective treatment for AR."

3. Neurofunction 
"In this regard, antioxidant potential of black pepper and its bioactive molecules is of considerable importance to improve brain function (Wattanathorn et al., 2008). Furthermore, the supplementation of piperine (5, 10 and 13 20mg/kg body/day) provides neuro-protection including improved cognitive function (Hanumanthachar and Miland, 2005; Lee et al., 2005). Li et al. (2007) previously investigated the antidepressant-like effect of piperine (2.5, 5 and 10 mg/kg). Their results revealed that piperine ameliorated the chronic mild stress due to changes in sucrose consumption, plasma corticosterone level, and open field activity. They commented that up-regulation of the progenitor cell proliferation of hippocampus, and cytoprotective activities are responsible for antidepressant-like effect of piperine. Later, Li et al. (2007) added that piperine treatment up-regulated brain-derived neurotrophic factor (BDNF) and mRNA expression. Additionally, Hu et al. (2009) indicated that piperine (10 & 20 mg/kg) improved the depression through reduction in ACTH and CRH levels thus ultimately leading to modulating hypothalamic-pituitary-adrenal (HPA) axis.. Recently, Bhutani et al. (2009) suggested to use piperine in combination with curcumin for the treatment of depressive disorders. The behavioral studies using forced swimming test (FST) and tail suspension test (TST) revealed that piperine is potent anti-depressant agent @ 10 & 20 mg/kg (Lee et al., 2005; Mohit et al., 2009; Liao 28 et al., 2009)." 
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180.  

"In one such study, Chonpathompikunlert et al., (2010) studied the effects of piperine in rat modeling and observed that piperine (5, 10 and 20 mg/kg BW) significantly improved memory impairment and neurodegeneration in hippocampus. Piperine and its analog (methyl piperate) have ability to restrain the monoamine oxidases (MAO) (Li et al., 2007; Naseri and Yahyavi, 2008) that is one of suitable strategy to prevent neurodegenerative problems such as Alzheimer’s and Parkinson’s (Kong et al., 2004; 8 Edmondson et al., 2007; Lee et al., 2008)." 
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180.  

"The results show that piperine exerts a protective effect on dopaminergic neurons via antioxidant, anti-apoptotic, and anti-inflammatory mechanisms in an MPTP-induced mouse model of PD. Thus, piperine is a potential therapeutic treatment for Parkinson's disease."
- Yang W, Chen YH, Liu H, Qu HD. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model. Int J Mol Med. 2015 Nov;36(5):1369-76. doi: 10.3892/ijmm.2015.2356. Epub 2015 Sep 28. PMID: 26648012.
4. Boosts absorption of nutrients and bioavailability of phytochemicals and drugs, Metabolic process
"As far absorption of piperine is concerned, it is absorbed from mucosal side (44-63%) that could be traced in intestinal tissue and serosal fluids (Suresh and Srinivasan, 2007). Piperine improves the functionality of gastrointestinal tract. The mechanisms of action include enhanced absorption of nutrients, improved enzymes synthesis, and perk-up defense capabilities. The examples include enhanced intestinal absorption of methionine & calcium ions, trace elements (selenium), vitamins B and β-carotene (Badmaev et al., 2000; Capasso et al., 2002). The amplified nutrient absorption is dependent upon the positive changes in permeability of intestinal cells membranes (Srinivasan, 2007)."
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"Recently, Okumura et al. (2010) presented the hypothesis that piperine intake may 5 decrease body weight and visceral fat accumulation through increased expression of 6 thermogenic protein uncoupling protein-1 in the mice. Badmaev et al. (1999) showed 7 that black pepper could speed the metabolic procedures that generate energy in the 8 human body. Although, the same process is responsible for sustaining weight loss but 9 recognized as playing an essential role in modulating nutrients absorption from diet." 
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"Concomitant administration of 20 mg of piperine with curcumin, however, produced much higher concentrations within 30 min to 1 h after drug treatment; piperine increased the bioavailability of curcumin by 2,000%."
- Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195-218. doi:10.1208/s12248-012-9432-8
5. Controls blood sugar
"It has been shown in a study conducted in normalmice by Panda and Kar (4) that piperine has hypo-glycemic effect... [We found that] there was significant lowering of blood glucose levels [with a peperine dose of 5 and 10 mg/kg] after 14 days ( p < 0.05... It is apparent from the above results that piper-ine has the potential to be used as an antidiabeticagent, if given repeatedly at the appropriate dosesover a period of time. Its acute effects of raising bloodglucose could also be used beneficially by using it incombination with known antidiabetics to counteracttheir adverse effect of hypoglycemia." 
[However,] "results of acute study showed that at 2 h post-dosing piperine at high dose of 40 mg/kg showed significant rise in blood glucose level (p < 0.05) in comparison to control group." 
- Atal S, Agrawal RP, Vyas S, Phadnis P, Rai N. Evaluation of the effect of piperine per se on blood glucose level in alloxan-induced diabetic mice. Acta Pol Pharm. 2012 Sep-Oct;69(5):965-9. Erratum in: Acta Pol Pharm. 2012 Nov-Dec;69(6):1395. PMID: 23061294.

"Methods and results: Among 24 spice extracts, the extracts from black pepper and white pepper significantly increase glucose uptake in L6 myotubes. Piperine is found to be the active compound in these extracts. Treatment of myotubes with piperine induces the translocation of glucose transporter 4 (GLUT4) to the plasma membrane by phosphorylation of AMP-activated protein kinase (AMPK). Piperine increases the intracellular Ca2+ level and reactive oxygen species (ROS) generation through transient receptor potential vanilloid channel 1 (TRPV1), followed by activation of Ca2+ /calmodulin-dependent protein kinase kinase-beta (CaMKKβ) as the upstream events for AMPK phosphorylation. Furthermore, oral administration of piperine to Wistar rats at 0.01 and 0.1 mg kg-1 body weight decreases postprandial hyperglycemia accompanied by GLUT4 translocation and AMPK phosphorylation. 
Conclusion: Piperine in pepper prevents hyperglycemia by GLUT4 translocation through CaMKKβ/AMPK signaling via TRPV1-dependent increase in the intracellular Ca2+ level and ROS generation." 
- Maeda A, Shirao T, Shirasaya D, Yoshioka Y, Yamashita Y, Akagawa M, Ashida H. Piperine Promotes Glucose Uptake through ROS-Dependent Activation of the CAMKK/AMPK Signaling Pathway in Skeletal Muscle. Mol Nutr Food Res. 2018 Jun;62(11):e1800086. doi: 10.1002/mnfr.201800086. Epub 2018 May 17. PMID: 29683271.

"This randomized, double blind, placebo-controlled, 8 week trial assessed the efficacy on metabolic changes produced by a consumption of a combination of bioactive food ingredients (epigallocatechin gallate, capsaicins, piperine and L-carnitine) versus a placebo, as part of a therapeutic 'lifestyle change' diet, in 86 overweight subjects. Forty-one patients (2/14 F/M; age 43.7 ± 8.5; BMI 30.3 ± 3.5 kg/m(2)) were randomized to the supplemented group and 45 (29/16; age 40.7 ± 10.2; BMI 30.0 ± 2.7) to the control group. We observed that consumption of the dietary supplement was associated with a significantly greater decrease in insulin resistance, assessed by homostasis model assessment (p < 0.001), leptin/adiponectin ratio (p < 0.04), respiratory quotient (p < 0.008). LDL-cholesterol levels (p < 0.01). Moreover, statistically significant differences were recorded between the two groups in relation to urinary norepinephrine levels (p < 0.001). Leptin, ghrelin, C-reactive protein decreased and resting energy expenditure increased significantly in the supplemented group (p < 0.05, 0.03, 0.02 and 0,02 respectively), but not in the placebo group; adiponectin decreased significantly in the placebo group (0.001) but not in the supplemented group, although no statistical significance between the groups was elicited. BMI, fat mass (assessed by DXA) and vascular endothelial growth factor significantly decreased, whilst the resting energy expenditure/free fat mass significantly increased in both groups. In general, a greater change was recorded in the supplemented group compared to the placebo, although no statistically significant difference between the two groups was recorded. These results suggest that the combination of bioactive food ingredients studied might be useful for the treatment of obesity-related inflammatory metabolic dysfunctions." 
- Rondanelli M, Opizzi A, Perna S, Faliva M, Solerte SB, Fioravanti M, Klersy C, Cava E, Paolini M, Scavone L, Ceccarelli P, Castellaneta E, Savina C, Donini LM. Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects. Endocrine. 2013 Oct;44(2):391-401. doi: 10.1007/s12020-012-9863-0. Epub 2012 Dec 28. Erratum in: Endocrine. 2013 Oct;44(2):402. Edda, Cava [corrected to Cava, Edda]; Maddalena, Paolini [corrected to Paolini, Maddalena]; Luciano, Scavone [corrected to Scavone, Luciano]; Paola, Ceccarelli [corrected to Ceccarelli, Paola]; Emanuela, Castellaneta [corrected to Castellaneta, Emanuela]; PMID: 23271695; PMCID: PMC3790246.
6. Lowers cholesterol 
"Hamsters were classified into eight groups: a normal control, atherogenic control and six other experimental groups (fed atherogenic diet supplemented with different doses of P. nigrum, P. guineense and P. umbellatum (1 and 0.25 g/kg) for 12 weeks. At the end of the feeding period the heart, liver and kidney from each group were analyzed for lipid profile and antioxidant enzymes activities. Atherogenic diet induced a significant (P<0.001) increase in the lipid profile across the board and equally significantly altered the antioxidant enzyme activities. Supplementation with Piper species significantly inhibited the alteration effect of atherogenic diet on the lipid profile and antioxidant enzymes activities. The Piper extracts may possess an antioxidant protective role against atherogenic diet induced oxidative stress in cardiac, hepatic and renal tissues." - Agbor GA, Akinfiresoye L, Sortino J, Johnson R, Vinson JA. Piper species protect cardiac, hepatic and renal antioxidant status of atherogenic diet fed hamsters. Food Chem. 2012 Oct 1;134(3):1354-9. doi: 10.1016/j.foodchem.2012.03.030. Epub 2012 Mar 23. PMID: 25005953.

Black pepper (Piper nigrum L.) lowers blood lipids in vivo and inhibits cholesterol uptake in vitro, and piperine may mediate these effects. To test this, the present study aimed to compare actions of black pepper extract and piperine on (1) cholesterol uptake and efflux in Caco-2 cells, (2) the membrane/cytosol distribution of cholesterol transport proteins in these cells, and (3) the physicochemical properties of cholesterol micelles. Piperine or black pepper extract (containing the same amount of piperine) dose-dependently reduced cholesterol uptake into Caco-2 cells in a similar manner. Both preparations reduced the membrane levels of NPC1L1 and SR-BI proteins but not their overall cellular expression. Micellar cholesterol solubility of lipid micelles was unaffected except by 1 mg/mL concentration of black pepper extract. These data suggest that piperine is the active compound in black pepper and reduces cholesterol uptake by internalizing the cholesterol transporter proteins.
- Duangjai A, Ingkaninan K, Praputbut S, Limpeanchob N. Black pepper and piperine reduce cholesterol uptake and enhance translocation of cholesterol transporter proteins. J Nat Med. 2013 Apr;67(2):303-10. doi: 10.1007/s11418-012-0682-7. Epub 2012 Jun 27. PMID: 22736065.

"Context: Piper nigrum Linn (Piperaceae) (PnL) is used in traditional medicine to treat gastric ailments, dyslipidemia, diabetes, and hypertension. 
 Objective: The present study explores the possible protective effects of P. nigrum extracts on high-fat diet-induced obesity in rats. 
 Materials and methods: High-fat diet-induced obese rats were treated orally with 200 mg/kg bw of different extracts (hexane, ethylacetate, ethanol, and aqueous extracts) of PnL for 42 d. The effects of PnL extracts on body composition, insulin resistance, biochemical parameters, leptin, adiponectin, lipid profile, liver marker enzymes, and antioxidants were studied. 
Results and discussion: The HFD control group rats showed a substantial raise in body weight (472.8 ± 9.3 g), fat% (20.8 ± 0.6%), and fat-free mass (165.9 ± 2.4 g) when compared with normal control rats whose body weight, fat%, and fat-free mass were 314.3 ± 4.4 g, 6.4 ± 1.4%, and 133.8 ± 2.2 g, respectively. Oral administration of ethyl acetate or aqueous extracts of PnL markedly reduced the body weight, fat%, and fat-free mass of HFD-fed rats. In contrast to the normal control group, a profound increase in plasma glucose, insulin resistance, lipid profile, leptin, thiobarbituric acid reactive substance (TBARS), and the activities of lipase and liver marker enzymes, and a decrease in adiponectin and antioxidant enzymes were noted in HFD control rats. Administration of PnL extracts to HFD-induced obese rats significantly (p < 0.05) restored the above profiles. Conclusion: PnL extracts significantly reduced the body weight, fat%, and ameliorated HFD-induced hyperlipidemia and its constituents."
- Parim B, Harishankar N, Balaji M, Pothana S, Sajjalaguddam RR. Effects of Piper nigrum extracts: Restorative perspectives of high-fat diet-induced changes on lipid profile, body composition, and hormones in Sprague-Dawley rats. Pharm Biol. 2015;53(9):1318-28. doi: 10.3109/13880209.2014.980585. Epub 2015 Apr 9. PMID: 25856709.
7. Anti-cancer properties 
"In this regard, Zhou et al. (2003) presented the evidences that the positive anticancer effects of piperine against benzo-pyrene induced lung carcinogenesis in mice model are due to its ability to 1 interaction with cytochrome P450 enzyme syste,. Later, Selvendiran et al. (2004) 2 explicated that piperine exhibited in vitro and in vivo dose-dependent inhibition of phase-I detoxification system (Bhardwaj et al., 2002). Moreover, piperine modulated the mitochondrial tricarboxylic acid cycle and glutathione-metabolizing enzymes in animal model lung carcinogenesis (Thirunavukkarasu et al., 2001; Vijayakumar et al., 2004; Suresh and Srinivasan, 2006). Later, Vellaichamy et al. (2009) examined the 7 chemopreventive potential of piperine (50mg/kg) against 7,12-8 dimethylbenz[a]anthracene (DMBA)-induced skin carcinogenesis. Piperine modulated the phase I & II detoxification system effectively thus ameliorating lipid peroxidation. In addition to aforementioned effects, the improvements in antioxidants status to normal are of significant importance for health care. Likewise, Krishnakumar et al. (2009) observed similar results in oral cancer bearing animals. Earlier, Nalini et al. (1998) observed that black pepper may protect the colon cancer by decreasing the activity of β-glucuronidase and mucinase. Pellitorine (terpinoids present in black 15 pepper) showed strong cytotoxic activities against HL60 and MCT-7 cell lines (Ee et al., 2010). Black pepper also counteracts cancer development directly (Selvendiran et al., 2004) through modification in enzyme kinetics to control the protein level in blood (Polovka and Suhaj, 2010). In another study, Bogomolny et al. (2008) supported some earlier studies that piperine owing to its potent antioxidant property can reduce protein expression thus modulating cell proliferation and transformation (Selvendiran et al., 2006). Research has revealed that pepper exerts a free-radical scavenging activity that assists in controlling the progression of some cancers. In some conditions, the same property can be useful in reducing the growth of cancer cells (Yadav and Bhatnagar, 2007). More recently, Liu et al. (2010) postulated that nearly all bioactive molecules of black pepper can suppress TNF-induced NF-kappaB activation. The extracts of black pepper at 200 microg/mL and its compounds at 25 µg/mL inhibited lipid peroxidation 27 by 45-85%, COX enzymes by 31-80% and cancer cells proliferation by 3.5-86.8%...Furthermore, black pepper and cardamom extracts collectively enhance the cytotoxic activity of 1 natural killer cells that indicate their potential anti-cancer effects (Majdalawieh and 2 Carr, 2010)."  
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"Piperine, a major alkaloid constituent of black pepper, exerts antitumor activities in a variety of cancers." 
- Zheng J, Zhou Y, Li Y, Xu DP, Li S, Li HB. Spices for Prevention and Treatment of Cancers. Nutrients. 2016;8(8):495. Published 2016 Aug 12. doi:10.3390/nu8080495
"Though no human trials have been performed, test-tube studies found that piperine slowed the replication of breast, prostate, and colon cancer cells and induced cancer cell death" 
- https://www.healthline.com/nutrition/black-pepper-benefits#6.-May-have-cancer-fighting-properties-
- Zheng J, Zhou Y, Li Y, Xu DP, Li S, Li HB. Spices for Prevention and Treatment of Cancers. Nutrients. 2016;8(8):495. Published 2016 Aug 12. doi:10.3390/nu8080495
8. Boosts gut health 
"[Black pepper] facilitates the digestion and reduces the food passage time in intestine by improving the digestive enzyme stimulation and saliva secretion. In addition to gastric protective functions, piperine extends its services in liver protection and bio-absorption of micronutrients, vitamins and trace elements. It helps increasing the bioavailability of many types of drugs and phytochemicals thus act as nutrient enhancer (Snyman et al., 2001; Capasso et al., 2002; Kumoro et al., 2009)."
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"The black pepper is used in conventional medicines as food adjunct to improve digestive system through various modules i.e. better appetite & absorption, and controlling dyspepsia & fleshiness."
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"It is widely accepted that black pepper is instrumental to prevent and cure gastrointestinal problems. The black pepper enhances the production of hydrochloric acid from stomach thus improving digestion through stimulation of histamine H2 receptors."
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"As far absorption of piperine is concerned, it is absorbed from mucosal side (44-63%) that could be traced in intestinal tissue and serosal fluids (Suresh and Srinivasan, 2007). Piperine improves the functionality of gastrointestinal tract. The mechanisms of action include enhanced absorption of nutrients, improved enzymes synthesis, and perk-up defense capabilities. The examples include enhanced intestinal absorption of methionine & calcium ions, trace elements (selenium), vitamins B and β-carotene (Badmaev et al., 2000; Capasso et al., 2002). The amplified nutrient absorption is dependent upon the positive changes in permeability of intestinal cells membranes (Srinivasan, 2007). Moreover, it protects intestinal membranes from gastric secretions and ROS damage owing to antioxidant potential. Moreover, black pepper significantly enhanced the activities of antioxidant enzymes i.e. SOD, catalase, GR, and GST. These mechanisms collectively lead to balanced mucosal health to provide gastro-protection (Irani, 2005; Chaudhry and Tariq, 2006; Prakash and Srinivasan, 2010). In addition to above, black pepper and its active ingredients improve expression of some digestive enzymes along with increase in the secretion of saliva. These collectively lead to facilitated digestion with reduced transit time in gastrointestinal tract (Kumoro et al., 2009; Bang et al., 2009; Kaefera and Milne, 2008). 
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 

"Black pepper along with its bioactive molecules can be used in constipation and 16 diarrhea. The mode of action of black pepper and its bioactive molecules involves 17 concentration-dependent & atropine-sensitive stimulant effect, spontaneous 18 contractions similar to loperamide and nifedipine, inhibition of naloxone-sensitive 19 effect, Ca(2+) channel blocking (CCB) activity, relaxant effect, K+ (80 mM)-induced 20 contractions. These mechanisms collectively leads to spasmodic (cholinergic) and 21 antispasmodic (opioid agonist and Ca (2+) antagonist) effects as narrated by Lambert et 22 al. (2004) and Mehmood and Gilani (2010). Overall, the results are quire conclusive to 23 warrant the utilization of black pepper and its ingredients to prevent and cure various 24 gastro-intestinal disorders." 
- Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875-86. doi: 10.1080/10408398.2011.571799. PMID: 23768180. 
9. Natural pain reliefer 
"Objective: To evaluate and compare the analgesic and anti-inflammatory activity of pure compound, piperine along with hexane and ethanol extracts of Piper nigrum L. fruit in mice and rats. 
 Methods: The analgesic activity was determined by tail immersion method, analgesy-meter, hot plate and acetic acid induced writhing test. While the anti-inflammatory activity was evaluated by carrageenan-induced paw inflammation in rats. 
 Results: Piperine at a dose of 5 mg/kg and ethanol extract at a dose of 15 mg/kg after 120 min and hexane extract at a dose of 10 mg/kg after 60 min exhibited significant (P<0.05) analgesic activity by tail immersion method, in comparison to ethanol extract at a dose of 10 mg/kg using analgesy-meter in rats. However, with hotplate method, piperine produced significant (P<0.05) analgesic activity at lower doses (5 and 10 mg/kg) after 120 min. A similar analgesic activity was noted with hexane extract at 15 mg/kg. However, in writhing test, ethanol extract significantly (P<0.05) stopped the number of writhes at a dose of 15 mg/kg, while piperine at a dose of 10 mg/kg completely terminated the writhes in mice. In the evaluation of anti-inflammatory effect using plethysmometer, piperine at doses of 10 and 15 mg/kg started producing anti-inflammatory effect after 30 min, which lasted till 60 min, whereas hexane and ethanol extracts also produced a similar activity at a slightly low dose (10 mg/kg) but lasted for 120 min. 
 Conclusions: It is concluded from the present study that Piper nigrum L possesses potent analgesic and anti-inflammatory activities." 
- Tasleem F, Azhar I, Ali SN, Perveen S, Mahmood ZA. Analgesic and anti-inflammatory activities of Piper nigrum L. Asian Pac J Trop Med. 2014 Sep;7S1:S461-8. doi: 10.1016/S1995-7645(14)60275-3. PMID: 25312168.

"The analgesic and anticonvulsant effects of piperine were studied in mice using acetic acid-induced writhing, tail flick assay, pentylenetetrazole (PTZ)- and picrotoxin (PIC)-induced seizures models. The intraperitoneal (i.p.) administration of piperine (30, 50 and 70 mg/kg) significantly inhibited (P<0.01) the acetic acid-induced writhing in mice, similar to the effect of indomethacin (20 mg/kg i.p.). In the tail flick assay, piperine (30 and 50 mg/kg, i.p.) and morphine (5 mg/kg, i.p.) caused a significant increase (P<0.01) in the reaction time of mice. Pre-treatment of animals with naloxone (5 mg/kg i.p.), reversed the analgesic effects of both piperine and morphine in the tail flick assay. Piperine (30, 50 and 70 mg/kg, i.p.) and standard drugs, valproic acid (200 mg/kg, i.p.), carbamazepine (30 mg/kg, i.p.) and diazepam (1 mg/kg, i.p.) significantly (P<0.01) delayed the onset of PTZ-and PIC-induced seizures in mice. These findings indicate that piperine exhibits analgesic and anticonvulsant effects possibly mediated via opioid and GABA-ergic pathways respectively. Moreover, piperine being the main constituent of black pepper, may be contributing factor in the medicinal uses of black pepper in pain and epilepsy."
- Bukhari IA, Pivac N, Alhumayyd MS, Mahesar AL, Gilani AH. The analgesic and anticonvulsant effects of piperine in mice. J Physiol Pharmacol. 2013 Dec;64(6):789-94. PMID: 24388894.

Banner

INDIVIDUALLY CHOSEN INGREDIENTS, FROM OUR FAMILY TO YOURS 

CHANGE YOUR WORLD NOT JUST YOUR BODY

FOLLOW THE SPICE ROUTE